BIOMAT Database Logo BIOMAT Database Logo

Long-term results and risk factors of quadruple immunosuppression in renal transplantation. 1999

C Hiesse, and F Kriaa, and P Eschwege, and S Boubenider, and S Marchand, and G Benoit, and B Charpentier
Department of Nephrology, Bicêtre Hospital, University Paris-Sud, Paris, France.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D012086 Reoperation A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery. Revision, Joint,Revision, Surgical,Surgery, Repeat,Surgical Revision,Repeat Surgery,Revision Surgery,Joint Revision,Revision Surgeries,Surgery, Revision
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft

Related Publications

C Hiesse, and F Kriaa, and P Eschwege, and S Boubenider, and S Marchand, and G Benoit, and B Charpentier
Donor and recipient risk factors and choice of immunosuppression determine long-term outcome in renal transplantation.
January 2001, Transplantation proceedings,
C Hiesse, and F Kriaa, and P Eschwege, and S Boubenider, and S Marchand, and G Benoit, and B Charpentier
Clinical results of quadruple drug immunosuppression in liver transplantation.
February 1992, Transplantation proceedings,
C Hiesse, and F Kriaa, and P Eschwege, and S Boubenider, and S Marchand, and G Benoit, and B Charpentier
Effects of deflazacort immunosuppression on long-term growth and growth factors after renal transplantation.
June 1997, Pediatric nephrology (Berlin, Germany),
C Hiesse, and F Kriaa, and P Eschwege, and S Boubenider, and S Marchand, and G Benoit, and B Charpentier
Long-term results of pancreas transplantation under tacrolius immunosuppression.
January 1999, Transplantation,
C Hiesse, and F Kriaa, and P Eschwege, and S Boubenider, and S Marchand, and G Benoit, and B Charpentier
Long-term results of renal transplantation.
December 1972, Transplantation proceedings,
C Hiesse, and F Kriaa, and P Eschwege, and S Boubenider, and S Marchand, and G Benoit, and B Charpentier
Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.
December 2010, Transplant infectious disease : an official journal of the Transplantation Society,
C Hiesse, and F Kriaa, and P Eschwege, and S Boubenider, and S Marchand, and G Benoit, and B Charpentier
Cardiac transplantation with corticosteroid-free immunosuppression: long-term results.
August 1991, The Annals of thoracic surgery,
C Hiesse, and F Kriaa, and P Eschwege, and S Boubenider, and S Marchand, and G Benoit, and B Charpentier
The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation.
February 1989, Transplantation proceedings,
C Hiesse, and F Kriaa, and P Eschwege, and S Boubenider, and S Marchand, and G Benoit, and B Charpentier
Tacrolimus versus cyclosporin immunosuppression: long-term outcome in renal transplantation.
May 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
C Hiesse, and F Kriaa, and P Eschwege, and S Boubenider, and S Marchand, and G Benoit, and B Charpentier
Risk factors affecting the long-term results of renal retransplantation.
November 1999, Transplantation proceedings,
Copied contents to your clipboard!